» Articles » PMID: 38180813

Rapid Human Genomic DNA Cloning into Mouse Artificial Chromosome Via Direct Chromosome Transfer from Human IPSC and CRISPR/Cas9-mediated Translocation

Abstract

A 'genomically' humanized animal stably maintains and functionally expresses the genes on human chromosome fragment (hCF; <24 Mb) loaded onto mouse artificial chromosome (MAC); however, cloning of hCF onto the MAC (hCF-MAC) requires a complex process that involves multiple steps of chromosome engineering through various cells via chromosome transfer and Cre-loxP chromosome translocation. Here, we aimed to develop a strategy to rapidly construct the hCF-MAC by employing three alternative techniques: (i) application of human induced pluripotent stem cells (hiPSCs) as chromosome donors for microcell-mediated chromosome transfer (MMCT), (ii) combination of paclitaxel (PTX) and reversine (Rev) as micronucleation inducers and (iii) CRISPR/Cas9 genome editing for site-specific translocations. We achieved a direct transfer of human chromosome 6 or 21 as a model from hiPSCs as alternative human chromosome donors into CHO cells containing MAC. MMCT was performed with less toxicity through induction of micronucleation by PTX and Rev. Furthermore, chromosome translocation was induced by simultaneous cleavage between human chromosome and MAC by using CRISPR/Cas9, resulting in the generation of hCF-MAC containing CHO clones without Cre-loxP recombination and drug selection. Our strategy facilitates rapid chromosome cloning and also contributes to the functional genomic analyses of human chromosomes.

Citing Articles

Microcell-mediated chromosome transfer between non-identical human iPSCs.

Uno N, Miyamoto H, Yamazaki K, Egawa M, Kobayashi H, Kazuki K Mol Ther Nucleic Acids. 2024; 35(4):102382.

PMID: 39634136 PMC: 11616053. DOI: 10.1016/j.omtn.2024.102382.


Generation of Monosomy 21q Human iPS Cells by CRISPR/Cas9-Mediated Interstitial Megabase Deletion.

Egawa M, Uno N, Komazaki R, Ohkame Y, Yamazaki K, Yoshimatsu C Genes Cells. 2024; 30(1):e13184.

PMID: 39581190 PMC: 11655957. DOI: 10.1111/gtc.13184.


Versatile plant genome engineering using anti-CRISPR-Cas12a systems.

He Y, Liu S, Chen L, Pu D, Zhong Z, Xu T Sci China Life Sci. 2024; 67(12):2730-2745.

PMID: 39158766 DOI: 10.1007/s11427-024-2704-7.

References
1.
Kneissig M, Keuper K, de Pagter M, van Roosmalen M, Martin J, Otto H . Micronuclei-based model system reveals functional consequences of chromothripsis in human cells. Elife. 2019; 8. PMC: 6910827. DOI: 10.7554/eLife.50292. View

2.
Moriwaki T, Abe S, Oshimura M, Kazuki Y . Transchromosomic technology for genomically humanized animals. Exp Cell Res. 2020; 390(2):111914. DOI: 10.1016/j.yexcr.2020.111914. View

3.
Cheng L, Wang H, Guo K, Wang Z, Zhang Z, Shen C . Reversine, a substituted purine, exerts an inhibitive effect on human renal carcinoma cells via induction of cell apoptosis and polyploidy. Onco Targets Ther. 2018; 11:1025-1035. PMC: 5833753. DOI: 10.2147/OTT.S158198. View

4.
Yoshimura Y, Nakamura K, Endo T, Kajitani N, Kazuki K, Kazuki Y . Mouse embryonic stem cells with a multi-integrase mouse artificial chromosome for transchromosomic mouse generation. Transgenic Res. 2015; 24(4):717-27. PMC: 4504986. DOI: 10.1007/s11248-015-9884-6. View

5.
Tamai M, Fujisawa S, Nguyen T, Komatsu C, Kagami K, Kamimoto K . Creation of Philadelphia chromosome by CRISPR/Cas9-mediated double cleavages on BCR and ABL1 genes as a model for initial event in leukemogenesis. Cancer Gene Ther. 2022; 30(1):38-50. PMC: 9842507. DOI: 10.1038/s41417-022-00522-w. View